Found by Accident Does Not Mean Harmless: What to Do About an Incidental Finding

These are incidental findings, and they are everywhere. Modern scanners are detailed enough to catch things no one went hunting for. Most turn out to be benign. But most is not all, and the honest answer is rarely a flat "ignore it" or a flat "panic." The right move is specific: name what kind of finding it is, apply the guideline written for it, and watch whether it changes. That last part, whether it moves over time, is what settles the question, and it is the thread Healz's memory is equipped to follow across every scan you have had.

Why your scan found something no one was looking for

Higher-resolution CT and MRI see more than the question that ordered them. A chest CT for a cough images the adrenal glands and the thyroid on its way through. An abdominal scan for pain catches the kidneys and the liver. The more detail the machine resolves, the more small, unrelated things it flags. Thyroid nodules alone show up on roughly 16 to 18 percent of neck CTs done for other reasons, and about 25 percent of CTs overall by one estimate (per ACR Incidental Thyroid Findings Committee). None of that means something is wrong. It means the scan is thorough, and thoroughness has a cost: findings that need sorting.

Benign is the base rate, not a guarantee

Here is the part that should lower your pulse. The large majority of incidental findings are benign. Almost all simple kidney cysts are harmless and need no action (per ACR Incidental Findings Committee). Most adrenal masses are non-functioning benign adenomas. Most thyroid nodules are benign, and the small cancers found this way tend to be indolent (per ACR white papers).

Here is the part that keeps it honest. "Most" is a base rate, not your result. A minority of adrenal incidentalomas quietly produce hormones or are malignant. A minority of lung nodules are early cancer. The whole point of a follow-up framework is to separate the common benign finding from the uncommon one that matters, without over-testing everyone to catch the few. That is why radiologists do not eyeball it. They apply published algorithms.

The follow-up depends on what kind of finding it is

There is no single rule for "a spot." The plan is set by the organ, the size, and your risk.

Lung nodule. The Fleischner Society 2017 guidelines are the standard for incidentally detected solid nodules in adults 35 and older (not lung-cancer screening, which uses Lung-RADS). They stratify by size. A solid nodule 6 mm or under in a low-risk person generally needs no routine follow-up. A 6 to 8 mm nodule gets a repeat CT at 6 to 12 months, then consideration of another at 18 to 24 months. Above 8 mm, the workup escalates. Intervals are given as ranges so risk and preference can shift them (Fleischner Society, Radiology 2017).

Adrenal mass. An incidental adrenal finding is seen on roughly 5 percent of abdominal CTs. The ACR adrenal white paper routes it by imaging features and history, but current endocrine guidance adds a step imaging cannot do: biochemical testing to exclude a hormone-producing tumor, specifically pheochromocytoma, subclinical Cushing's syndrome, and hyperaldosteronism (per ACR Incidental Findings Committee).

Kidney. A simple renal cyst is benign, and you can be reassured. A complex or partly solid cystic mass is stratified by the Bosniak categories, which decide whether it is followed or investigated (per ACR Incidental Findings Committee).

Thyroid. On CT or MRI, the ACR incidental thyroid algorithm, not the ultrasound TI-RADS system, sizes and ages the finding to decide who needs a dedicated thyroid ultrasound. Very small nodules generally need no follow-up at all (per ACR Incidental Thyroid Findings Committee).

If you want to actually read the report the finding came in on, our guides to how to read an MRI report and how to read a PET/CT scan report walk through the hedge language and the impression line that so often blurs what to do next.

The number that matters is the change, not the first measurement

Almost every incidentaloma framework comes down to one question over time: is it stable? A 7 mm nodule that has not budged across two scans a year apart is a different animal from a 7 mm nodule that was 4 mm last year. The first is reassuring. The second gets attention. Stability over time is one of the strongest signals that a finding is benign, which is why the guidelines schedule repeat imaging instead of one-and-done biopsies.

That makes your old scans the most valuable data you own, and it is exactly where the system usually fails you. This year's CT sits in one hospital portal. Last year's MRI is in another. The prior measurement is buried in a paragraph nobody reopens. When the comparison is not made, a stable finding gets re-worked as if it were new, or a growing one gets called stable because no one lined up the numbers.

How Healz handles an incidental finding

An incidental finding is a tracking problem before it is anything else, and tracking is where scattered records drop it. Healz puts the whole thing in one chat instead of ten apps. Frontier AI works your case, so an ai ct scan analysis or online mri report analysis ai reads the finding in the full context of your record, not as an isolated line. Healz is equipped with root-cause technology, so it does not stop at the label a report assigns; it cross-checks your finding against 1M+ cases and asks what the guideline actually recommends for a finding of that size, that type, at your risk. And Healz's memory holds every prior scan you upload and connects the dots across years, so when a follow-up scan arrives it is measured against the last one, the comparison that tells you whether a nodule is stable or growing. When you want a human read, you can bring a board-certified doctor into the same chat for a second opinion.